| | Class 2 Device Recall BioFire FilmArray Gastrointestinal (GI) Panel |  |
| Date Initiated by Firm | May 16, 2024 |
| Date Posted | August 06, 2024 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2514-2024 |
| Recall Event ID |
94992 |
| 510(K)Number | K140407 K143005 K160459 K230404 |
| Product Classification |
Gastrointestinal pathogen panel multiplex nucleic acid-based assay system - Product Code PCH
|
| Product | BIOFIRE FILMARRAY Gastrointestinal (GI) Panel REF RFIT-ASY-0116
(30 test kit)
BIOFIRE FILMARRAY Gastrointestinal (GI) Panel REF RFIT-ASY-0104
(6 kit test)
The BIOFIRE FILMARRAY Gastrointestinal (GI) Panel is a qualitative multiplexed nucleic acid-based in vitro diagnostic test intended for use with BIOFIRE FILMARRAY Systems. The BIOFIRE GI Panel is capable of the simultaneous detection and identification of nucleic acids from multiple bacteria, viruses, and parasites directly from stool samples in Cary Blair transport media obtained from individuals with signs and/or symptoms of gastrointestinal infection. |
| Code Information |
Part Number: RFIT-ASY-0116 (30 test kit)
UDI-DI code: 00815381020109
0081538102011:
All unexpired products are potentially impacted if used in conjunction with the Remel Cary Blair transport medium
Part Number: RFIT-ASY-0104 (6 test kit)
UDI-DI code: 0081538102011
All unexpired products are potentially impacted if used in conjunction with the Remel Cary Blair transport medium
Remel Cary-Blair Transport Medium lot numbers:
743930
769240
712258
782425
732357
742049 |
| FEI Number |
3002773840
|
Recalling Firm/ Manufacturer |
BioFire Diagnostics, LLC 515 S Colorow Dr Salt Lake City UT 84108-1248
|
| For Additional Information Contact | Customer Support Department 800-736-6354 Ext. 5 |
Manufacturer Reason for Recall | Due to increase of false positive Vibrio/Vibrio Cholerae results when using a certain transport medium. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On 07/11/2024, the firm emailed an "URGENT FIELD SAFETY NOTICE" to customers informing them the firm has identified an increased risk of false positive Vibrio/Vibrio Cholerae results when the BIOFIRE GI Panel is used with certain lots of Remel" Cary-Blair transport medium (see Appendix A - Affected Remel" Cary-Blair Lots).
Customers are instructed to:
-If the BIOFIRE GI Panel is used in conjunction with certain lots of Remel" Cary-Blair (Lot # 743930, 769240, 712258, 782425, 732357, and 742049), positive results for Vibrio/Vibrio Cholerae should be confirmed by another method prior to reporting the test results.
-Distribute this information to all appropriate personnel in your laboratory, retain a copy for your files, post this letter in or near the laboratory, and forward this information to all parties that may use this product, including others to whom you may have transferred our product.
-Complete the Acknowledgement Form in Attachment A and return it to usfieldactions@biomerieux.com, so that bioMrieux may acknowledge your receipt of this notification. It is important that you return the acknowledgment form to bioMrieux even if you determine this urgent field safety notice does not impact your facility.
For assistance or any questions, contact the bioMrieux Technical Support Center by email at BioFireSupport@biomerieux.com or (800) 682-2666. The anticipated turnaround time for email inquiries is 24 48 hours during normal business hours. |
| Quantity in Commerce | 67,613 kits (or 2,028,309 pouches). Each pouch is used for each individual test. |
| Distribution | U.S.: Nationwide - AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, Puerto Rico, RI, SC, SD, TN, TX, UT, VA, Virgin Island, VT, WA, WI, WV, and WY.
O.U.S.: Worldwide - AR, AU, AT, BE, BR, CA, CL, HK, CN, CO, CZ, DE, FI, FR, GR, HU, IN, IT, JP, MX, NL, NO, PH, PL, PT, SG, ZA, KR, ES, SE, CH, TW, TH, TR, GB, AL, DZ, AO, AM, BH, BY, BO, BA, BW, BG, CR, HR, CY, CD, DO, AN, EC, SV, EE, FJ, GE, GU, GT, GN, HT, HN, IS, ID, IQ, IE, IL, CI, CI, JO, KE, KW, LV, LB, LT, MO, MY, ML, MR, MD, MN, MA, MM, NP, NZ, NZ, NI, OM, PK, PA, PG, PY, PE, QA, RO, SA, RS, SI, TN, TR, UY, AE, VE, VN, and ZW.
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = PCH 510(K)s with Product Code = PCH
|
|
|
|